Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 28,408 followers.

12) This appears to cause intractable changes in volume regulation, sodium homeostasis, inflammation, & metabolism that lead to cardiorenal disease and mortality. 🔓https://t.co/6hiM930SLe

20 Sep 2022

Reply Repost Favourite

RT @ckd_ce: 12) This appears to cause intractable changes in volume regulation, sodium homeostasis, inflammation, & metabolism that lead to…

12 Apr 2022

Reply Repost Favourite

RT @ckd_ce: 12) This appears to cause intractable changes in volume regulation, sodium homeostasis, inflammation, & metabolism that lead to…

12 Apr 2022

Reply Repost Favourite

RT @ckd_ce: 12) This appears to cause intractable changes in volume regulation, sodium homeostasis, inflammation, & metabolism that lead to…

12 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.